| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |